The viruses in our genes: When activated, they damage brain development

Since our ancestors infected themselves with retroviruses millions of years ago, we have carried elements of these viruses in our genes – known as human endogenous retroviruses, or HERVs for short. These viral elements have lost their ability to replicate and infect during evolution, but are an integral part of our genetic makeup. In fact, humans possess five times more HERVs in non-coding parts than coding genes. So far, strong focus has been devoted to the correlation of HERVs and the onset or progression of diseases. This is why HERV expression has been studied in samples of pathological origin. Although important, these studies do not provide conclusions about whether HERVs are the cause or the consequence of such disease.

Today, new technologies enable scientists to receive a deeper insight into the mechanisms of HERVs and their function. Together with her colleagues, virologist Michelle Vincendeau* has now succeeded for the first time in demonstrating the negative effects of HERV activation on human brain development.

Using CRISPR technology, the researchers activated a specific group of human endogenous retroviruses** in human embryonic stem cells and generated nerve cells (neurons). These viral elements in turn activated specific genes, including classical developmental factors, involved in brain development. As a result, cortical neurons, meaning the nerve cells in our cerebral cortex, lost their function entirely. They developed very differently from healthy neurons in this brain region – with much a shorter axon (nerve cell extension) that were much less branched. Thus, activation of one specific HERV group impairs cortical neuron development and ultimately brain development.

Since neurodegenerative diseases are often associated with the activation of several HERV groups, the negative impact of HERV activation on cortical neuron development is an essential finding. It is already known that environmental factors such as viruses, bacteria, and UV light can activate distinct HERVs, thereby potentially contributing to disease onset. This knowledge, in turn, makes HERVs even more interesting for clinical application. Switching off distinct viral elements could open up a new field of research for the treatment of patients with neurodegenerative diseases. In a next step, the group at Helmholtz Zentrum München will study the impact of HERV deactivation in neurons in the context of disease.

In addition, the research findings provide important indications that epigenetic mechanisms keep viral elements under control in healthy brain development. Michelle Vincendeau even suspects a functional role for the controlled HERVs in normal brain development. “We have carried these elements for about 40 to 70 million years. We assume that their presence is relevant to our natural processes, otherwise we would not have retained them for so long during evolution,” Vincendeau says. Further basic research in this direction might reveal new functional roles for HERVs.

###

* Michelle Vincendeau leads the research group for Human Endogenous Retroviruses at the Institute of Viorology at Helmholtz Zentrum München. Part of the data from the current study was generated in the context of her previous work at the Memorial Sloan Kettering Cancer Center in New York. For this paper, she also collaborated with researchers at the Technical University of Munich and the University of Saarland.

** HERV-K(HML-2)

Nair et al., 2021: Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3. Cell Stem Cell, DOI: 10.1016/j.stem.2021.04.009

Helmholtz Zentrum München is a research center with the mission to discover personalized medical solutions for the prevention and therapy of environmentally-induced diseases and promote a healthier society in a rapidly changing world. It investigates important common diseases which develop from the interaction of lifestyle, environmental factors and personal genetic background, focusing particularly on diabetes mellitus, allergies and chronic lung diseases. Helmholtz Zentrum München is headquartered in Neuherberg in the north of Munich and has about 2,500 staff members. It is a member of the Helmholtz Association, the largest scientific organization in Germany with more than 40,000 employees at 18 research centers.